Brief: Kashiv Biosciences Agrees To Be Acquired By Amneal Pharmaceuticals To Create A Fully Integrated Global Biosimilar Leader
22/04/2026 11:54
April 22 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O: KASHIV BIOSCIENCES AGREES TO BE ACQUIRED BY AMNEAL PHARMACEUTICALS TO CREATE A FULLY INTEGRATED GLOBAL BIOSIMILAR LEADER AMNEAL PHARMA: TRANSACTION IS EXPECTED TO CLOSE IN SECOND HALF OF 2026 Source text: ID:nBw3RFG5Va Further company coverage: AMRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsFocus: US progesterone supplies tighten as menopause treatment demand grows
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies, Cypherpunk Technologies
Amneal Pharma up after Parkinson’s drug shows benefit in late-stage study